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Background: Stoichiometric models provide a structural framework for analyzing steady-state cellular behavior.
Models are developed either through augmentations of existing models or more recently through automatic
reconstruction tools. There is currently no standardized practice or method for validating the properties of a model
before placing it in the public domain. Considerable effort is often required to understand a model’s inconsistencies
before its reuse within new research efforts.
Results: We present a review of common issues in stoichiometric models typically uncovered during pathway
analysis and constraint-based optimization, and we detail succinct and efficient ways to find them. We present MC3,
Model and Constraint Consistency Checker, a computational tool that can be used for two purposes: (a) identifying
potential connectivity and topological issues for a given stoichiometric matrix, S, and (b) flagging issues that arise
during constraint-based optimization. The MC3 tool includes three distinct checking components. The first examines
the results of computing the basis for the null space for Sv = 0; the second uses connectivity analysis; and the third
utilizes Flux Variability Analysis. MC3 takes as input a stoichiometric matrix and flux constraints, and generates a
report summarizing issues.
Conclusions: We report the results of applying MC3 to published models for several systems including
Escherichia coli, an adipocyte cell, a Chinese Hamster Ovary cell, and Leishmania major. Several issues with no
prior documentation are identified. MC3 provides a standalone MATLAB-based comprehensive tool for model
validation, a task currently performed either ad hoc or implemented in part within other computational tools.
Keywords: Constraint-based modeling, Pathway analysis, Model validation, Consistency checking, Model reuseBackground
Stoichiometric models play a fundamental role in the
analysis and optimization of biochemical networks in
Systems Biology and Metabolic Engineering, especially
in the absence of detailed kinetic models. A stoichiomet-
ric model specifies the relative quantities of reactants
and products for each reaction within a network. There
are two fundamental and commonly used computational
techniques that utilize stoichiometric models to eluci-
date steady-state function. The first technique is Elem-
entary Flux Mode (EFM) analysis [1,2], used to find all
non-decomposable pathways that can operate in steady
state. EFM analysis has been used to analyze robustness
and regulation [1,3,4], analyze microbial stress responses
[5], increase product yield [6], and assess plant fitness* Correspondence: soha.hassoun@tufts.edu
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distribution, and reproduction in any mediumand agricultural productivity [7]. Another fundamental
technique is Constraint-Based Modeling (CBM), used to
analyze flux flow in metabolic networks. CBM encom-
pass several techniques including, Flux Balance Analysis
(FBA) [8,9], and Flux-Variability Analysis (FVA) [10].
CBM has recently been extended and applied in innova-
tive ways. Examples include performing whole-genome
simulation combining FBA with kinetic rate expressions
(dFBA) [11], determining an optimal set of gene modifica-
tions with the goal of increasing the production of desired
target metabolites [12,13], analyzing genotype–phenotype
relationship [14], and performing thermodynamic feasibil-
ity analysis [15].
Stoichiometric structural models are traditionally con-
structed manually, based on earlier models and in
combination with reaction availability from databases.
An example is the formulation of successive models of
the E. coli organism that lead to improved predictiventral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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The recent availability of genome, reaction, and organism
specific databases have allowed for the automatic recon-
struction of genome-scale models. A protocol encompass-
ing 94 steps details the process including obtaining a draft
construction from databases, collecting experimental data,
refining the reconstruction by adding details to ensure
that the network is mass and charge balanced and that
missing reactions steps are properly flagged, to test the
ability of the model to grow, and to compare against
known properties [17]. The tool, Model SEED, expedites
this process by automating most of the steps; however,
manual curation is still needed to refine the constructed
model [18]. The quality of the reconstruction, whether
obtained manually or automatically, is as comprehensive
as the availability of reconstruction and experimental data,
and is a function of the reconstruction procedure. The
resulting models may thus be incomplete or inconsistent
for the purpose of steady-state analysis. Models can be
updated once new information (e.g. genome annotation,
reaction directionality) or more accurate reconstruction
tools become available.
This paper addresses identifying model inconsistencies
in the context of steady-state analysis. Anecdotes within
the community show that models released in the public
domain often have undocumented inconsistencies, such
as dead-end metabolites or reactions incapable of carrying
fluxes. While some model issues have been documented
[19], there is currently no standalone computational tool
that ensures model and constraint consistency. Each user
is thus forced to personally validate a model, sometimes in
ad hoc and incomplete manners. Alternatively, the user
may remain unaware of model issues as some tools work
around such issues. For example, in EFMTool [20], a tool
for computing Elementary Modes, dead-end metabolites
and fluxes that carry a zero flux are removed from the
network prior to EFM computation, as part of network
compression to speed the EFM computation. Frequently,
it is an incorrect computational result that alerts the user
to model inconsistencies. In addition to the lack of standa-
lone computational tools for model validation, there is
currently no standard documentation protocol that each
model undergoes prior to public release. Ideally, each
model should provide clear documentation on potential
model inconsistency a user might encounter when perfor-
ming common steady-state analysis tasks such as EFM
analysis or CBM. End users would benefit tremendously
from a standardized way of identifying and documenting
model issues.
We provide in this paper a detailed survey of issues
common in stoichiometric models. Each type of issue is
identified and explained, and current mechanisms for
validating each are reported. The main contribution of
this article is to succinctly clarify in one centralizeddocument how each model or constraint property can
be most efficiently identified. This paper can be of great
benefit to users that wish to implement their own model
and constraint consistency checks. We also describe a
software tool that we developed, Model & Constraint
Consistency Checker (MC3), which performs model and
constraint consistency checking. The MATLAB code that
implements this tool is available freely through the web.
Methods
Modeling of biochemical networks
A biochemical network is represented using a stoichiomet-
ric matrix S [21,22]. If a network has m compounds and n
reactions, the corresponding matrix S will be an m by n
matrix. An entry in the matrix represents the stoichiometric
coefficient of a compound participating in a particular reac-
tion. Each column describes a reaction. A column entry is
zero if the compound does not participate in the reaction,
positive if the compound is a product and negative if the
compound is a reactant. Reactions in a network can be
classified as exchange or internal reactions. An exchange
reaction links a biochemical network to its external envir-
onment, as defined by the user, and provides either uptake
and/or production of external metabolites. Exchange reac-
tions are also referred to as external boundary conditions.
Non-exchange reactions are referred to as internal reac-
tions that connect internal metabolites. Reactions can be
reversible, and are sometimes split into forward and reverse
reactions during steady-state and flux balance analysis. Each
row in S specifies the mass balance relationship for a
particular metabolite. During steady-state analysis, external
metabolites are excluded from the S matrix, while exchange
reactions are included. In the example in Figure 1a, there
are three internal compounds (B, C and E), three external
compounds (A, D and F), and six reactions (R1, R2, R3,
R4, R5 and R6). The compound ordering in the stoi-
chiometric matrix in Figure 1b corresponds to B, C, and
E; external compounds are not included in the matrix;
exchange reactions are R1, R5, and R6.
During steady-state analysis, each internal metabolite in
the network is produced and consumed at the same net
rate, so that there is no accumulation of internal metabo-
lites. Therefore, when each row in S, which describes how
each reaction balances a particular metabolite, multiplies
v, the steady state flux vector, the result must be equal to a
zero vector, indicating a zero metabolite accumulation or




 vj ¼ 0; i ∈ 1; ::;mf g; ð1Þ
where Sij is the entry in the i
th row and the jth column in
S. Thus, at steady state:
Figure 1 Example biochemical network. (a) R1, R5, and R6
represent exchange reactions, and A, D, and F represent external
metabolites. (b) The corresponding stoichiometric matrix. (c)
Mass-balance constraints under steady-state conditions.
Figure 2 Illustration of common model issues. Metabolites D and
H are dead-end metabolites as they are only being produced and
not consumed. Reactions R2, R3, R4, R5, R7 and R8 are identified by
FVA as zero-flux reactions. R1 is an unsatisfied reversible reaction
and can carry flux in only one direction. R5 and R8 form a reversibly
coupled reaction pair.
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Any v that satisfies this equation is in the null space
(kernel) of S. The mass-balance constraints for the example
in Figure 1a are illustrated in Figure 1c.
Computing flux balance and flux variability analysis
Flux Balance Analysis (FBA) is a computational ap-
proach to find the flux through the network by solving
Sv = 0. Typically, the S matrix is underdetermined, and
many solutions satisfy the steady-state condition. An
objective function is typically added to this constraint.
FBA is commonly formulated as a linear optimization
problem, where the objective function either maximizes
or minimizes a desired reaction flux or a combination of
desired fluxes, subject to Eq. 2. Additional constraints
are used to bound flux ranges. Example constraints are
ones that limit uptake or secretion of compounds
through exchange reactions, or ones that model the
effects of knockouts, and up/down regulation. Users can
specify the stoichiometric matrix, the objective function,
and the desired bounds in generic linear optimizationprograms such as GNU Linear Programming Kit (GLPK)
and linprog (a linear optimization toolbox within
MATLAB), or with a tool such as the COBRA Toolbox
[23]. Within the COBRA Toolbox, the default upper and
lower bounds are [−1000 1000] for reversible reactions,
and [0 1000] for irreversible ones. Flux Variability Ana-
lysis (FVA) consists of identifying the minimum and
maximum range for each flux subject to steady state
condition (Eq. 2) and other model constraints such as
uptake or exchange rates. While calculating the mini-
mum and the maximum flux values for each reaction, all
external boundaries are set to 0 or −1000 (depending on
their reversibility) and 1000. These bounds are reason-
able considering typical stoichiometric coefficients of
metabolic networks.
Common model issues
Several model and constraint consistency issues arise in
practice. The most common is when the model has a
dead-end metabolite. There are two existing definitions
in the literature for a dead-end metabolite. One defin-
ition, termed herein as Singly Connected Metabolite
(SCM), specifies internal metabolites with only one
participating reaction as a dead-end metabolite [24]. An-
other definition, termed Dead-End Metabolite (DEM), is
when a metabolite internal to the network is either con-
sumed or produced, but not both [20,25]. Both defini-
tions are illustrated in Figure 2. Using definition SCM, H
is identified as a singly ended metabolite. Using DEM,
both H and D are dead-end metabolites. H is clearly a
dead-end metabolite as it will be accumulating during
the steady-state operation of the network. If the reaction
directionality is correctly specified, and the model has a
gap, then D will also accumulate during steady-state
operation. Indeed, a non-zero flux value when producing
H (through R4) or producing D (through R5 and R8)
will violate steady-state constraints imposed by Eq. 1
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incorrectly, then alerting the user that D is a dead-end
metabolite will help the user correct the directionality of
R5 or R8, if appropriate. In either case, the user should
be alerted that the metabolites have some connectivity
issues, and he/she can then determine the correct course
of action. Both SCM and DEM conditions are detected
by examining S, as follows:
Condition SCM. Singly connected metabolite
A metabolite i is has a single connection iff
Sij ∀j; Sij ≠ 0gj ¼ 1

where {Sij| ∀j, Sij ≠ 0} refers to the set of non-zero entries
in the row associated with metabolite i, and the vertical
bars refer to the cardinality (number of elements) in that
set.
Condition DEM. Dead-end metabolite
A metabolite i is a dead-end metabolite iff
∀j : Sij ≥ 0 ∨ ∀j : Sij ≤ 0; j∈ 1;…;mf g
where the symbol ∨ corresponds to a logical OR
operation.
A second common issue is when a network contains a
reaction (ri) that can only carry a zero flux for any
possible steady-state condition. Several reasons may
cause this issue, including ri directly connecting to a
dead-end metabolite or to another zero-flux reaction, or
if the reversibility of the reaction is specified incorrectly.
Burgard et al. refer to zero-flux reactions as blocked
reactions [4]. A subset of zero-flux reactions can be
detected by analyzing the basis of the null space to
ensure that each row has at least one non-zero entry
[20]. This method identifies zero-flux reactions due to a
connection to a dead-end metabolite, (e.g. R4 is con-
nected to H in Figure 2). However, the null-space basis
will not identify R2, R5, R7 and R8 as zero-flux reactions
because the null-space basis computation is oblivious to
the ability of a reaction to carry flux only in a particular
direction. FVA, on the other hand, is capable of identify-
ing all zero-flux reactions in the network. The set of
zero-flux reactions is identified by maximizing and min-
imizing the flux of each reaction subject to the network
stoichiometry and some bounds [20]. If the maximum
and minimum flux of a reaction is zero, then it is a
zero-flux reaction. The zero-flux reactions detected by
FVA are a superset of the zero-flux reactions identi-
fied from the null-space basis vectors. There is thus
only need to use FVA and not both FVA and the basis
vectors to identify zero-flux reactions. In our tool, we
utilize FVA to identify zero-flux reactions using the fol-
lowing condition:Condition ZFR. Zero-flux reaction
A reaction rj is a zero-flux reaction iff
vjmax ¼ 0
 
∧ vjmin ¼ 0
 
where the symbol ∧ corresponds to a logical AND oper-
ation, vjmax refers to the maximum flux value for reaction
rj obtained using FVA, and vjmin refers to the minimum
flux value for reaction rj obtained using FVA.
A third common issue that can be detected by inspect-
ing FVA results is an unsatisfied reversibility condition
associated with a reversible reaction. Sometimes reactions
marked as reversible carry flux only in one direction.
Terzer uses LP-based feasibility analysis to find unsatisfied
reversible reactions [20]. An unsatisfied reversibility con-
dition was found if the minimum or maximum flux value
is zero for a reversible reaction. This definition, however,
excludes reactions that have a non-zero positive minimum
or a non-zero negative maximum from consideration.
Here, we expand the definition of unsatisfied reversibility
to additionally include reversible reactions that can carry
only positive non-zero or only negative non-zero flux.
Once identified, reactions identified as having unsatisfied
reversibility can be marked if appropriate, as only-forward
or only-backward based on the signs of their fluxes.
We detect unsatisfied reversibility using the following
condition:
Condition UR. unsatisfied reversibility





where the symbol ∨ corresponds to logical OR opera-
tion. Some zero-flux reversible reactions can also be
declared as zero-flux reactions.
Another steady-state characteristic of interest is flux
coupling among a pair or group of irreversible reactions.
Such pairs or groups have been referred to as “enzyme
subsets” [26] and they were shown to have similar
expression patterns, share transcriptional regulators, and
frequently reside in the same operon [27]. Knowledge of
coupled reactions enables finding equivalent knockouts
and, when used in conjunction with directionality data,
enables the identification of missing reactions in a re-
construction [4]. If the fluxes of two reactions are always
constant multiples of each other, then the reactions are
coupled. If additionally the constant multiplier is nega-
tive, then the reaction pair is labeled as reversibly
coupled. Such conditions can be detected by checking
the null-space basis matrix and examining the coupling
ratios [20,26]. We detect coupling using the following
conditions.
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¼ ⋯ ¼ bip
bjp
where bi* is a row in the null-space basis of the S matrix
associated with a reaction i, bik and bjk are either both
zero, or both non-zero entries in the kth column in the
null-space basis matrix, and p is the number of columns
in the basis matrix.
Condition RCR. reversibly coupled reactions







¼ ⋯ ¼ bip
bjp
< 0
The set of reactions with condition RCR is a subset of
the reactions in CR.
MC3 implementation
Despite the availability of literature coverage of some
of the issues described in the previous section, there
is clearly a need to develop a computational tool to
perform model and constraint consistency checking in
a comprehensive, and standalone way. Such a tool
enables each user to check his or her model before
releasing it to others to ensure that constraints are
consistent and the model can be exercised as desired.
A user may exercise the tool upon receiving a model
from another user or when obtaining a model from aFigure 3 MC3 tool overview.database or supplementary material. Additionally, such a
tool can be utilized as a front-end to other tools that
utilize stoichiometric models. To this end, we describe a
software tool that we developed, the Model & Constraint
Consistency Checker (MC3) tool. As mentioned earlier,
MC3 code is implemented using MATLAB [28]. How-
ever, before running MC3, two software dependencies,
namely the SBML toolbox [29] and GLPK [30] need
to be installed.
Figure 3 provides an overview of MC3. Initially, the S
matrix is read. Three types of computations (in boxes)
are used: null-space basis analysis, connectivity analysis,
and FVA analysis. Each computation checks the appro-
priate conditions marked in the ovals.
The main module of MC3 is mc_checkmodel. It reads
the model and runs the checks specified by its check-
Type parameter. The first parameter of mc_checkmodel
is the model type, which can either be ‘xls’ or ‘SBML’
[31] depending on the model type. The second param-
eter is checkType which can be 0, 1, or 2, where 0 corre-
sponds to running only checks based on the null-space
basis vectors (Conditions CR, RCR), 1 corresponds to
running only checks based on FVA (Condition ZFR and
UR), and 2 corresponds to running checks using both.
Conditions SCM and DEM are always checked. The
third parameter is the filename. If the file type is ‘xls’,
then the remaining parameters are the Excel sheets for
the stoichiometry, exchange reactions, external metabo-
lites, and user-defined bounds. The S matrix is formatted
with rows as metabolites and columns as reactions. The
last row specifies reaction reversibility (1 for reversible,
and 0 for irreversible). Every cell should have a
Table 1 Summary of tool comparison




Dead-end metabolite ● ● ● ●








'●' refers to the presence of a functionality.
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a single column. Each entry contains the index of an ex-
change reaction. The external metabolites are also
expressed as a single column. Each entry contains a row
number of the relevant metabolite. The S matrix is
stripped of all external metabolites before analysis. The
external metabolite listing is therefore optional. The lower
and upper bound arrays for FVA analysis are expressed as
two columns. The first is the lower bound array and the
second column is the upper bound array. There must be
one row for each reaction in the S matrix and each entry
within the row must contain a numerical value. The flux
bounds are optional. If not specified, MC3 uses the upper
and lower bounds [−1000 1000] for reversible reactions,
and [0 1000] for irreversible ones. If the file type is ‘SBML’,
then the remaining parameters are arrays containing the ex-
change reactions, external metabolites, and user-defined
bounds. The exchange reactions are expressed as a single
column. Each entry contains a reaction ID. The external
metabolites are also expressed as a single column. Each
entry contains a metabolite ID. The bonds are specified as
they were for the xls’ case. All three parameters are optional.
An example of running mc_checkmodel with all checks
for the SBML formatted model (Ec_iAF1260_flux1) [32] is
provided. The function is run as follows:
[SCM, DEM, ZFR, UR, CR, RCR] = mc_checkmodel
(‘SBML’, 2, ‘Ec_iAF1260_flux1.xml’, ‘ExchangeReactions’,
‘ExternalMetabolites’, ‘OverrideUserBounds’);
When the command finishes executing, the return
elements (SCM, DEM … ) are arrays that contain indices
of either metabolites or reactions that pertain to that
check, or will be empty if that check did not return any
results. The indices can be correlated with the SBML file
by examining the struct that holds the S matrix, and
reaction and metabolite names. The example model,







87 Singly connected metabolites (SCM)
118 dead-end metabolites (DEM)
Basis-based checks:
970 coupled reactions (CR)
45 reversibly coupled reactions (RCR)
FVA-based checks:
184 zero-flux reactions (ZFR)
420 unsatisfied reversibility (UR)The report has four sections. The first reports various
statistics associated with the network and ensures that the
whole network was read in. The second section reports the
results of connectivity analysis. The third section reports the
results from the analysis that used the basis vectors. In the
last section, we report the results of FVA-based analysis.
We have compared the functionality of MC3 with other
available tools, namely, the COBRA toolbox [23], CellNetA-
nalyzer [33] and MetaNetX [34,35]. While dead-end metab-
olites can be determined using all these tools, zero-flux
reactions are only reported using MC3, CellNetAnalyzer
and MetaNetX. Both MC3 and MetaNetX can find coupled
reactions. All other discussed issues can only be identified
using MC3. The comparison is summarized in Table 1.
Results and discussion
We checked the consistency of some available models
using MC3. The checked models included those of
E.coli (3 different sizes) [6,25,32], adipocyte [36], Chinese
Hamster Ovary (CHO) cell [37], and L. major [38]. For
every test case, MC3 checks for all conditions speci-
fied in section ‘Common Model issues’. A summary
of the results is shown in Table 2.
The E. coli central metabolic network [6], composed of
70 reactions and 53 internal metabolites (52 internal
metabolites as reported in the paper [6] plus BIOMASS),
captures the conversion of sugars to ethanol. For this
network, MC3 reports two dead-end metabolite (BIO-
MASS and ATP_main) and three related zero-flux reac-
tions. In the supplementary section of the paper [6], it is
noted that metabolite names containing ‘ext’ are external
metabolites. BIOMASS was thus treated as an internal
metabolite. BIOMASS and ATP_main each appear only
in one reaction. Both BIOMASS and ATP_main are thus
identified by MC3 as dead-end metabolites. Reactions
directly connected to these metabolites are identified as
zero-flux reactions.
E. coli model iJR904 [25] contains 70 dead-end metab-
olites that are listed in the additional data file. These
metabolites participate in 89 reactions that will never be
engaged if the network operates at steady state. The









(e) SCM (f) DEM (g) ZFR (h) UR (i) CR (j) RCR
Minimal E. Coli 53 70 15 19 2 2 3 8 14 0
E. Coli iJR904 761 1075 143 388 56 67 150 196 325 8
E. Coli iAF1260 1668 2382 299 852 87 118 184 461 970 32
adipocyte 26 34 7 0 0 0 0 0 10 0
CHO cell 231 275 34 108 0 0 0 53 540 0
Leishmania major 1101 1112 64 630 250 259 376 374 156 9
For each model, the number of metabolites, reactions, exchange reactions and reversible reactions are indicated in columns a-d. The results of applying MC3 are
indicated in columns: (e) Singly Connected Metabolites (SCM), (f) Dead-End Metabolites (DEM), (g) Zero-Flux Reactions (ZFR), (h) Unsatisfied Reversibility (UR),
(i) Coupled Reactions (CR), and (j) Reversibly Coupled Reactions (RCR).
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iJR904 are purposefully included for later amendments
when more annotation data is available. MC3 identifies
67 dead-end metabolites and 150 zero-flux reactions in
this network. The difference in the number of dead-end
metabolites compared to the reported results is due to
metabolites cardiolipin, lipopolysaccharide, and peptido-
glycan. Each participates as a reactant in the biomass
reaction.
E. coli model iAF1260 [32] is a reconstructed model
based on iJ904R. The model documentation (Table 2)
reports 304 exchange reactions, while the published
model has only 299 exchange reactions. The authors
state clearly that there are some dead-end metabolites
within the model but do not provide specific documen-
tation. MC3 identifies 118 dead-end metabolites and 184
zero-flux reactions based on the FVA computation. The
model documentation reports using thermodynamic fea-
sibility and flux variability analysis to adjust the model
based on assessing reaction reversibilities; however, we
identified 461 out of 852 reversible reactions that still had
unsatisfied reversibilities.
The Adipocyte model is a small network with 26
metabolites and 34 reactions [36]. This model does not
have any of the discussed issues.
The CHO cell model capturing the central carbon
metabolism is part of a larger network [37]. The revers-
ibility of reactions in this model is derived from the
KEGG database, and reaction directions are also derived
from KEGG. MC3, however, identifies 53 reactions that
operate only in one direction.
For the L. major model [38], 261 dead-end metabolites
are reported. MC3 is able to find 259 dead-end meta-
bolites and 376 zero-flux reactions based on the FBA
computation, which include the reactions connected
directly to the dead-end metabolites or connected to the
other zero-flux reactions. There are 374 unsatisfied
reversible reactions.
It is important to realize that our tool (and others) can
only validate a subset of inconsistencies associated witha particular model. Further, the tool validates properties
of the model, and not the correctness of the model or
the reconstruction. For example, MC3 identifies the
conditions for dead-end metabolites. The end user is to
decide how to interpret this result – it can be due to an
incomplete reconstruction or perhaps an incorrect sign
in the file specifying the model. Another example is
specifying incorrectly the coefficients of a particular
reaction. The issue of intent vs. specification exists in
verification and validation of other engineering and
software systems. MC3 cannot verify the intent, but it
can certainly validate some aspects (properties) of the
model. Validation of biological models will become more
prominent in this field with its maturity, and with the
increase use of automated reconstruction tools.Conclusions
While model and consistency constraint issues have
been identified in various contexts, this article offers a
review and detailed methodology for checking common
issues. All checks are packaged within MC3, a tool
available for others to validate their model. The results of
applying MC3 to several models have found some incon-
sistencies between the models and their respective pub-
lished articles. It would be important for the community
to have a standard method of documenting and reporting
issues with each published models. The MC3 MATLAB
files are available by contacting the authors or through
GitHub at https://github.com/sohahassoun/mc3.Abbreviations
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